Total Funding
34
1
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1190782
Melcap develops miniature gastric neurostimulator system for the treatment of obesity and overweight.
- Josef More: Chief Financial Officer, Head of Financial Department, Co-Founder
- Boris Voznesensky: Chief Technology Officer
About the Company
Gastric Electrical Stimulation (GES) has been formally proven as one of the possible alternatives for the treatment of obesity: There are several companies nowadays who use the GES technology for the treatment of obesity; however, these companies use an implantable devices, which are expensive, invasive and may cause medical complications in the
future.Melcap’s innovative system is a non-invasive low cost device, yet it uses the same GES technology for its treatment.
